Trade TLSA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Tiziana Life Sciences Ltd. Common Shares (TLSA) is trading at US$1.01, down 6.48% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$145.08M. Over the past 52 weeks, TLSA has traded between US$0.87 and US$2.35. On Syfe you can trade TLSA with $0 commission and add it to your watchlist.
| Previous close | US$1.08 |
|---|---|
| Market cap | US$145.08M |
| 52-week range | US$0.87 – US$2.35 |
| Volume | 565K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Tiziana Life Sciences Ltd. Common Shares
Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company, which engages in developing therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer’s. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom.
Year: 2018
Sector Update: Healthcare Stocks Lower in Afternoon Trading
Jul 22, 5:38 PM · MT Newswires
Tiziana Life Sciences Says Executive Chairman Gabriele Cerrone Boosts Stake
Jul 22, 1:15 PM · MT Newswires
Tiziana Life Sciences Doses Last Patient in Phase 2 Trial of Potential Multiple Sclerosis Treatment
Jun 25, 11:35 AM · MT Newswires
Tiziana Life Sciences Executive Chairman Gabriele Cerrone Increases Holdings
Jun 15, 11:55 AM · MT Newswires
Tiziana Life Sciences Completes Patient Enrollment for Phase 2a Multiple Sclerosis Trial
May 21, 3:39 PM · MT Newswires
Stay on top of TLSA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
